Kamuran Ibis

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Exploring e-health literacy levels among Turkish women diagnosed with breast cancer: a cross-sectional study.

Exploring e-health literacy levels among Turkish women diagnosed with breast cancer: a cross-sectional study.

Journal: BMC public health

Published: November 20, 2025

The "Undefined and Ignored Normal Tissue" Bulboclitoral Complex in Locally Advanced Cervical Cancer Treated with Definitive Radiochemotherapy: Is It Not the Organ at Risk?

The "Undefined and Ignored Normal Tissue" Bulboclitoral Complex in Locally Advanced Cervical Cancer Treated with Definitive Radiochemotherapy: Is It Not the Organ at Risk?

Journal: Medicina (Kaunas, Lithuania)

Published: November 16, 2025

Machine Learning-Based Prognostic Modelling Using MRI Radiomic Data in Cervical Cancer Treated with Definitive Chemoradiotherapy and Brachytherapy.

Machine Learning-Based Prognostic Modelling Using MRI Radiomic Data in Cervical Cancer Treated with Definitive Chemoradiotherapy and Brachytherapy.

Journal: Current oncology (Toronto, Ont.)

Published: September 21, 2025

A Comparative Study of Five Target Volume Definitions for Radiotherapy in Glioblastoma Multiforme.

A Comparative Study of Five Target Volume Definitions for Radiotherapy in Glioblastoma Multiforme.

Journal: Medicina (Kaunas, Lithuania)

Published: September 14, 2025

Prognostic Significance of Nomogram and T-Score in Locally Advanced Cervical Cancer Patients Treated with Curative Chemoradiotherapy and Image-Guided Brachytherapy: A Single-Center Retrospective Study.

Prognostic Significance of Nomogram and T-Score in Locally Advanced Cervical Cancer Patients Treated with Curative Chemoradiotherapy and Image-Guided Brachytherapy: A Single-Center Retrospective Study.

Journal: Diagnostics (Basel, Switzerland)

Published: July 27, 2025

Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.

Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.

Journal: Journal of breast cancer

Published: March 01, 2025

De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer.

De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer.

Journal: JAMA surgery

Published: January 02, 2025

ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered.

ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered.

Journal: Annals of surgical oncology

Published: November 20, 2024

Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.

Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.

Journal: Annals of surgical oncology

Published: August 23, 2024

Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.

Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.

Journal: World journal of surgical oncology

Published: July 09, 2024

Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided.

Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided.

Journal: Cancer

Published: March 04, 2024

Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.

Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.

Journal: Journal of cancer research and clinical oncology

Published: July 03, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026